tiprankstipranks
Trending News
More News >
CSPC Pharmaceutical Group Limited (CHJTF)
OTHER OTC:CHJTF
US Market

CSPC Pharmaceutical Group (CHJTF) Stock Forecast & Price Target

Compare
28 Followers
See the Price Targets and Ratings of:

CHJTF Analyst Ratings

Strong Buy
11Ratings
Strong Buy
10 Buy
1 Hold
0 Sell
Based on 11 analysts giving stock ratings to
CSPC
Pharmaceutical Group
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

CHJTF Stock 12 Month Forecast

Average Price Target

$1.60
▲(15.94% Upside)
Based on 11 Wall Street analysts offering 12 month price targets for CSPC Pharmaceutical Group in the last 3 months. The average price target is $1.60 with a high forecast of $2.46 and a low forecast of $1.24. The average price target represents a 15.94% change from the last price of $1.38.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"0":"$0","1":"$1","2":"$2","3":"$3","-1":"-$1"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":2.46294125,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$2.46</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":1.6,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$1.60</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":1.2410665,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$1.24</span>\n  </div></div>","useHTML":true}}],"tickPositions":[-1,0,1,2,3],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"May<br/>2025","6":"Aug<br/>2025","9":"Nov<br/>2025","12":"Feb<br/>2026","25":"Feb<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1.2,1.297149326923077,1.3942986538461537,1.4914479807692307,1.5885973076923077,1.6857466346153847,1.7828959615384616,1.8800452884615384,1.9771946153846154,2.074343942307692,2.171493269230769,2.268642596153846,2.365791923076923,{"y":2.46294125,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1.2,1.2307692307692308,1.2615384615384615,1.2923076923076924,1.323076923076923,1.353846153846154,1.3846153846153846,1.4153846153846155,1.4461538461538461,1.476923076923077,1.5076923076923077,1.5384615384615385,1.5692307692307694,{"y":1.6,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1.2,1.2031589615384615,1.206317923076923,1.2094768846153845,1.2126358461538462,1.2157948076923077,1.2189537692307693,1.2221127307692308,1.2252716923076923,1.2284306538461538,1.2315896153846155,1.234748576923077,1.2379075384615386,{"y":1.2410665,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":0.563,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.585,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.544,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.62,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.84,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.973,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.239,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 5</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.254,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 5</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.081,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 16, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 5</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.989,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 15, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 4</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.005,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 14, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 4</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.961,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 45, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.2,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 46, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$2.46Average Price Target$1.60Lowest Price Target$1.24
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Bernstein Analyst forecast on CHJTF
Bernstein
Bernstein
$1.37
Hold
-0.80%
Downside
Reiterated
02/09/26
Bernstein Sticks to Their Hold Rating for CSPC Pharmaceutical Group (CHJTF)
CMB International Securities Analyst forecast on CHJTF
CMB International Securities
CMB International Securities
$1.41$1.78
Buy
29.15%
Upside
Reiterated
02/02/26
Analysts' Top Healthcare Picks: Tonix Pharma (TNXP), CSPC Pharmaceutical Group (CHJTF)
Huatai Securities Analyst forecast on CHJTF
Unknown Analyst
Huatai Securities
Not Ranked
Huatai Securities
$1.63$2.46
Buy
78.47%
Upside
Reiterated
02/02/26
Huatai Securities Reaffirms Their Buy Rating on CSPC Pharmaceutical Group (CHJTF)
Goldman Sachs Analyst forecast on CHJTF
Unknown Analyst
Goldman Sachs
Not Ranked
Goldman Sachs
$1.35$1.52
Buy
10.05%
Upside
Reiterated
02/02/26
Goldman Sachs Reaffirms Their Buy Rating on CSPC Pharmaceutical Group (CHJTF)
CICC Analyst forecast on CHJTF
Unknown Analyst
CICC
Not Ranked
CICC
$1.41$1.54
Buy
11.26%
Upside
Reiterated
01/31/26
CICC Sticks to Its Buy Rating for CSPC Pharmaceutical Group (CHJTF)
Guoyuan Securities (HK) Analyst forecast on CHJTF
Unknown Analyst
Guoyuan Securities (HK)
Not Ranked
Guoyuan Securities (HK)
$1.29
Buy
-6.27%
Downside
Reiterated
12/10/25
CSPC Pharmaceutical Group (CHJTF) Gets a Buy from Guoyuan Securities (HK)
First Shanghai Securities Analyst forecast on CHJTF
Unknown Analyst
First Shanghai Securities
Not Ranked
First Shanghai Securities
$1.28
Buy
-7.01%
Downside
Reiterated
12/08/25
CSPC Pharmaceutical Group (CHJTF) Receives a Buy from First Shanghai Securities
Guotai Haitong Analyst forecast on CHJTF
Unknown Analyst
Guotai Haitong
Not Ranked
Guotai Haitong
$1.68$1.45
Buy
5.14%
Upside
Reiterated
11/26/25
Guotai Haitong Reaffirms Their Buy Rating on CSPC Pharmaceutical Group (CHJTF)
Macquarie Analyst forecast on CHJTF
Macquarie
Macquarie
$1.65$1.59
Buy
14.97%
Upside
Reiterated
11/25/25
Analysts Are Bullish on These Healthcare Stocks: Sanofi (SNYNF), CSPC Pharmaceutical Group (CHJTF)
Citic Securities Analyst forecast on CHJTF
Unknown Analyst
Citic Securities
Not Ranked
Citic Securities
$2.05
Buy
48.34%
Upside
Reiterated
11/25/25
Citic Securities Remains a Buy on CSPC Pharmaceutical Group (CHJTF)
Shenwan Hongyuan Analyst forecast on CHJTF
Unknown Analyst
Shenwan Hongyuan
Not Ranked
Shenwan Hongyuan
$1.24
Buy
-10.07%
Downside
Reiterated
11/24/25
Shenwan Hongyuan Reaffirms Their Buy Rating on CSPC Pharmaceutical Group (CHJTF)
BOCOM International Holdings Company Analyst forecast on CHJTF
Unknown Analyst
BOCOM International Holdings Company
Not Ranked
BOCOM International Holdings Company
$0.93
Hold
-32.32%
Downside
Reiterated
11/21/25
Bank of China Analyst forecast on CHJTF
Unknown Analyst
Bank of China
Not Ranked
Bank of China
$1.09
Sell
-21.19%
Downside
Reiterated
11/21/25
CLSA Analyst forecast on CHJTF
Unknown Analyst
CLSA
Not Ranked
CLSA
$2.23
Buy
61.32%
Upside
Reiterated
11/21/25
UOB Kay Hian Analyst forecast on CHJTF
Unknown Analyst
UOB Kay Hian
Not Ranked
UOB Kay Hian
$1.09
Sell
-21.19%
Downside
Downgraded
11/21/25
UOB Kay Hian downgrades CSPC Pharmaceutical Group (CHJTF) to a Sell
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Bernstein Analyst forecast on CHJTF
Bernstein
Bernstein
$1.37
Hold
-0.80%
Downside
Reiterated
02/09/26
Bernstein Sticks to Their Hold Rating for CSPC Pharmaceutical Group (CHJTF)
CMB International Securities Analyst forecast on CHJTF
CMB International Securities
CMB International Securities
$1.41$1.78
Buy
29.15%
Upside
Reiterated
02/02/26
Analysts' Top Healthcare Picks: Tonix Pharma (TNXP), CSPC Pharmaceutical Group (CHJTF)
Huatai Securities Analyst forecast on CHJTF
Unknown Analyst
Huatai Securities
Not Ranked
Huatai Securities
$1.63$2.46
Buy
78.47%
Upside
Reiterated
02/02/26
Huatai Securities Reaffirms Their Buy Rating on CSPC Pharmaceutical Group (CHJTF)
Goldman Sachs Analyst forecast on CHJTF
Unknown Analyst
Goldman Sachs
Not Ranked
Goldman Sachs
$1.35$1.52
Buy
10.05%
Upside
Reiterated
02/02/26
Goldman Sachs Reaffirms Their Buy Rating on CSPC Pharmaceutical Group (CHJTF)
CICC Analyst forecast on CHJTF
Unknown Analyst
CICC
Not Ranked
CICC
$1.41$1.54
Buy
11.26%
Upside
Reiterated
01/31/26
CICC Sticks to Its Buy Rating for CSPC Pharmaceutical Group (CHJTF)
Guoyuan Securities (HK) Analyst forecast on CHJTF
Unknown Analyst
Guoyuan Securities (HK)
Not Ranked
Guoyuan Securities (HK)
$1.29
Buy
-6.27%
Downside
Reiterated
12/10/25
CSPC Pharmaceutical Group (CHJTF) Gets a Buy from Guoyuan Securities (HK)
First Shanghai Securities Analyst forecast on CHJTF
Unknown Analyst
First Shanghai Securities
Not Ranked
First Shanghai Securities
$1.28
Buy
-7.01%
Downside
Reiterated
12/08/25
CSPC Pharmaceutical Group (CHJTF) Receives a Buy from First Shanghai Securities
Guotai Haitong Analyst forecast on CHJTF
Unknown Analyst
Guotai Haitong
Not Ranked
Guotai Haitong
$1.68$1.45
Buy
5.14%
Upside
Reiterated
11/26/25
Guotai Haitong Reaffirms Their Buy Rating on CSPC Pharmaceutical Group (CHJTF)
Macquarie Analyst forecast on CHJTF
Macquarie
Macquarie
$1.65$1.59
Buy
14.97%
Upside
Reiterated
11/25/25
Analysts Are Bullish on These Healthcare Stocks: Sanofi (SNYNF), CSPC Pharmaceutical Group (CHJTF)
Citic Securities Analyst forecast on CHJTF
Unknown Analyst
Citic Securities
Not Ranked
Citic Securities
$2.05
Buy
48.34%
Upside
Reiterated
11/25/25
Citic Securities Remains a Buy on CSPC Pharmaceutical Group (CHJTF)
Shenwan Hongyuan Analyst forecast on CHJTF
Unknown Analyst
Shenwan Hongyuan
Not Ranked
Shenwan Hongyuan
$1.24
Buy
-10.07%
Downside
Reiterated
11/24/25
Shenwan Hongyuan Reaffirms Their Buy Rating on CSPC Pharmaceutical Group (CHJTF)
BOCOM International Holdings Company Analyst forecast on CHJTF
Unknown Analyst
BOCOM International Holdings Company
Not Ranked
BOCOM International Holdings Company
$0.93
Hold
-32.32%
Downside
Reiterated
11/21/25
Bank of China Analyst forecast on CHJTF
Unknown Analyst
Bank of China
Not Ranked
Bank of China
$1.09
Sell
-21.19%
Downside
Reiterated
11/21/25
CLSA Analyst forecast on CHJTF
Unknown Analyst
CLSA
Not Ranked
CLSA
$2.23
Buy
61.32%
Upside
Reiterated
11/21/25
UOB Kay Hian Analyst forecast on CHJTF
Unknown Analyst
UOB Kay Hian
Not Ranked
UOB Kay Hian
$1.09
Sell
-21.19%
Downside
Downgraded
11/21/25
UOB Kay Hian downgrades CSPC Pharmaceutical Group (CHJTF) to a Sell
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering CSPC Pharmaceutical Group

3 Months
xxx
Success Rate
9/13 ratings generated profit
69%
Average Return
+14.68%
reiterated a xxx
rating 22 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 69.23% of your transactions generating a profit, with an average return of +14.68% per trade.
1 Year
Yolanda HuMorgan Stanley
Success Rate
3/3 ratings generated profit
100%
Average Return
+26.73%
reiterated a buy rating 6 months ago
Copying Yolanda Hu's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +26.73% per trade.
2 Years
xxx
Success Rate
13/13 ratings generated profit
100%
Average Return
+75.62%
reiterated a xxx
rating 22 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +75.62% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

CHJTF Analyst Recommendation Trends

Rating
Oct 25
Nov 25
Dec 25
Jan 26
Feb 26
Strong Buy
11
14
12
16
13
Buy
0
0
0
0
0
Hold
16
15
14
45
46
Sell
5
4
4
3
0
Strong Sell
0
0
0
0
0
total
32
33
30
64
59
In the current month, CHJTF has received 13 Buy Ratings, 46 Hold Ratings, and 0 Sell Ratings. CHJTF average Analyst price target in the past 3 months is 1.60.
Each month's total comprises the sum of three months' worth of ratings.

CHJTF Financial Forecast

CHJTF Earnings Forecast

Next quarter’s earnings estimate for CHJTF is $0.02 with a range of $0.02 to $0.02. The previous quarter’s EPS was $0.01. CHJTF beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.43% of the time in the same period. In the last calendar year CHJTF has Performed in-line its overall industry.
Next quarter’s earnings estimate for CHJTF is $0.02 with a range of $0.02 to $0.02. The previous quarter’s EPS was $0.01. CHJTF beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.43% of the time in the same period. In the last calendar year CHJTF has Performed in-line its overall industry.

CHJTF Sales Forecast

Next quarter’s sales forecast for CHJTF is $1.10B with a range of $1.06B to $1.13B. The previous quarter’s sales results were ―. CHJTF beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 49.17% of the time in the same period. In the last calendar year CHJTF has Performed in-line its overall industry.
Next quarter’s sales forecast for CHJTF is $1.10B with a range of $1.06B to $1.13B. The previous quarter’s sales results were ―. CHJTF beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 49.17% of the time in the same period. In the last calendar year CHJTF has Performed in-line its overall industry.

CHJTF Stock Forecast FAQ

What is CHJTF’s average 12-month price target, according to analysts?
Based on analyst ratings, CSPC Pharmaceutical Group Limited’s 12-month average price target is 1.60.
    What is CHJTF’s upside potential, based on the analysts’ average price target?
    CSPC Pharmaceutical Group Limited has 15.94% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is CHJTF a Buy, Sell or Hold?
          CSPC Pharmaceutical Group Limited has a consensus rating of Strong Buy which is based on 10 buy ratings, 1 hold ratings and 0 sell ratings.
            What is CSPC Pharmaceutical Group Limited’s price target?
            The average price target for CSPC Pharmaceutical Group Limited is 1.60. This is based on 11 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $2.46 ,the lowest forecast is $1.24. The average price target represents 15.94% Increase from the current price of $1.38.
              What do analysts say about CSPC Pharmaceutical Group Limited?
              CSPC Pharmaceutical Group Limited’s analyst rating consensus is a Strong Buy. This is based on the ratings of 11 Wall Streets Analysts.
                How can I buy shares of CHJTF?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.